Who
Matthew K. Szot
Director
Company insider
Files Form 4 as: Director, SenesTech; Chief Financial Officer, Cadrenal Therapeutics; Director, INVO Fertility; EVP Finance & Admin and CFO, S&W Seed Co; Director, Beeline Holdings; Chief Financial Officer, Quantum Information.
In numbers
- Trades disclosed
- 290
- Buys
- 4
- Sells
- 33
- Bought
- $19K
- Sold
- $850K
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 22 Jan 2009
- Last trade
- 15 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 17 Jun 2026 | SNES SenesTechoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | SNES SenesTechoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 29 Dec 2025filed 31 Dec 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $69K9,933 at $6.97 | filing |
| 4 Dec 2025filed 5 Dec 2025 | IVF INVO FertilityMedical Devices | SEC FORM 4 Code J | —3 at $0.00 | filing |
| 3 Dec 2025filed 5 Dec 2025 | IVF INVO FertilityMedical Devices | SEC FORM 4 Sold | $64 at $1.52 | filing |
| 14 Nov 2025filed 17 Nov 2025 | SNES SenesTechAgricultural Chemicals & Fertilizers | SEC FORM 4 Sold | $31 at $2.75 | filing |
| 27 Oct 2025filed 28 Oct 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $25K1,800 at $13.99 | filing |
| 24 Oct 2025filed 28 Oct 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $25K1,800 at $13.99 | filing |
| 13 Oct 2025filed 14 Oct 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $25K1,800 at $14.07 | filing |
| 9 Oct 2025filed 14 Oct 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K1,693 at $13.99 | filing |
| 6 Oct 2025filed 7 Oct 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,497107 at $13.99 | filing |
| 1 Oct 2025filed 1 Oct 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K1,700 at $13.99 | filing |
| 29 Sep 2025filed 1 Oct 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,400100 at $14.00 | filing |
| 25 Sep 2025filed 26 Sep 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $153K10,900 at $14.05 | filing |
| 24 Sep 2025filed 26 Sep 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K1,500 at $14.00 | filing |
| 28 Aug 2025filed 29 Aug 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,600400 at $14.00 | filing |
| 27 Aug 2025filed 29 Aug 2025 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Sold | $22K1,600 at $14.00 | filing |
| 26 Aug 2025filed 28 Aug 2025 | IVF INVO Fertilityoption or derivative · Medical Devices | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 23 Jan 2025filed 24 Jan 2025 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 27 Aug 2024filed 28 Aug 2024 | SNES SenesTechoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —12,090 at $0.00 | filing |
News
Cadrenal Therapeutics (NASDAQ:CVKD) Shares Climb 12.4% – Here's WhyCVKD · tickerreport.com · 18 Oct 2026Comparing INVO Fertility (NASDAQ:IVF) & Nutex Health (NASDAQ:NUTX)IVF · themarketsdaily.com · 17 Oct 2026SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential GrowthSNES · finanznachrichten.de · 15 Oct 2026Reviewing INVO Fertility (NASDAQ:IVF) & Auna (NYSE:AUNA)IVF · tickerreport.com · 13 Oct 2026Analyzing Nutex Health (NASDAQ:NUTX) & INVO Fertility (NASDAQ:IVF)IVF · tickerreport.com · 10 Oct 2026
0 headlines in the last 90 days name Matthew K. Szot; 5 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.